BAFF and its receptors:contribution and therapeutic potential in atherosclerosis [ 2012 - 2014 ]

Research Grant

Researchers: Prof Ban-Hock Toh (Principal investigator) ,  A/Pr Peter Tipping ,  Prof Alexander Bobik

Brief description Atherosclerosis is an inflammatory reaction to cholesterol in blood vessels. Despite cholesterol-lowering statins, atherosclerosis-based heart attacks and strokes remain a major cause of deaths. Studies of BAFF, a pro-inflammatory molecule can shed new light on the inflammation. As BAFF blockers are already in clinical trials to treat inflammatory diseases, our study has potential to lead to using BAFF blockers to treat human atherosclerosis.

Funding Amount $AUD 562,742.09

Funding Scheme Project Grants

Notes Standard Project Grant